495
edits
EVOLVE: Difference between revisions
Jump to navigation
Jump to search
→Baseline Characteristics
Michaelw2000 (talk | contribs) No edit summary |
Michaelw2000 (talk | contribs) Tag: visualeditor |
||
| Line 90: | Line 90: | ||
* Anticipated parathyroidectomy within 6 months after randomization | * Anticipated parathyroidectomy within 6 months after randomization | ||
===Baseline Characteristics=== | ===Baseline Characteristics=== | ||
==== Demographics ==== | |||
''From the cinacalcet group.'' | ''From the cinacalcet group.'' | ||
* Age: 55.0y | * Age: 55.0y | ||
| Line 113: | Line 115: | ||
Significant differences were reported between mean dBP (p=0.02) and TIA (P<0.05). | Significant differences were reported between mean dBP (p=0.02) and TIA (P<0.05). | ||
Biochemical | '''Biochemical''' | ||
''From all patients.'' | |||
* Hemoglobin: 11.8 g/dL | * Hemoglobin: 11.8 g/dL | ||
* BUN: 61.9 mg/dL) | * BUN: 61.9 mg/dL) | ||
* Creatinine: 10.1 mg/dL | * Creatinine: 10.1 mg/dL | ||
* Dialysis dose | * Dialysis dose ≥1.2 spKt/V or ≥ 65 URR | ||
* Serum calcium: 9.8 mg/dL | * Serum calcium: 9.8 mg/dL | ||
* Serum phospohorus: 6.5 mg/dL | * Serum phospohorus: 6.5 mg/dL | ||
* Serum Ca * P | * Serum (Ca*P)²: 63.2 mg/dL | ||
* Serum Potassium: 5.1 mEq/L | * Serum Potassium: 5.1 mEq/L | ||
* PTH: 691.8 pg/mL | * PTH: 691.8 pg/mL | ||
| Line 127: | Line 131: | ||
* Randomization by blocks according to country and diabetes status | * Randomization by blocks according to country and diabetes status | ||
* All groups received conventional therapy: | * All groups received conventional therapy: | ||
** Dialysis, phosphate binders, vitamin D sterols, calcium supplements, other medications | ** Dialysis, phosphate binders, vitamin D sterols, calcium supplements, other medications | ||
** Prescribed at the discretion to the treating physicians encouraged to follow clinical practice guidelines | ** Prescribed at the discretion to the treating physicians encouraged to follow clinical practice guidelines | ||
* Cinacalcet group received: | * Cinacalcet group received: | ||
** Starting dose of 30mg daily | ** Starting dose of 30mg daily | ||